Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Switching of BJT01:22

Switching of BJT

865
Switching behavior in Bipolar Junction Transistors (BJTs) is a fundamental aspect utilized in various electronic circuits, particularly for digital logic applications like switches and amplifiers. In a typical switching circuit, a BJT alternates between cut-off and saturation modes, corresponding to the "off" and "on" states, respectively, thus behaving like an ideal switch.
Cut-off Mode ("Off" State): In this state, both the emitter-base and collector-base junctions are...
865
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

1.6K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.6K
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

940
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
940
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

1.6K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.6K
The Placebo Effect01:54

The Placebo Effect

6.9K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.9K
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

6.4K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
6.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Influence of preconception period and pregnancy on birth outcomes and health of the child].

Nederlands tijdschrift voor tandheelkunde·2025
Same author

Socioecological correlates of parental lifestyle patterns during the antenatal period.

The international journal of behavioral nutrition and physical activity·2025
Same author

Skin-brain dialogue in auto-inflammatory diseases: A new route to biomarkers?

Brain, behavior, & immunity - health·2024
Same author

Distinct alterations in probabilistic reversal learning across at-risk mental state, first episode psychosis and persistent schizophrenia.

Scientific reports·2024
Same author

Current preconception care practice in the Netherlands - An evaluation study among birth care professionals.

Midwifery·2023
Same author

Jean Talairach (1911-2007). An untold story of the pioneer of stereotactic and functional neurosurgery.

Neuro-Chirurgie·2022
Same journal

Measuring antidepressant side effects in military personnel - Clinical validation of the French version of the UKU-SERS-Pat Scale: A comparative study of patient and clinician ratings.

L'Encephale·2026
Same journal

[Empowerment in addictology].

L'Encephale·2026
Same journal

Evaluation of the links between smoking and conspiracy mentality.

L'Encephale·2026
Same journal

Use of a relevance assessment tool in therapeutic residential care: A real world study.

L'Encephale·2026
Same journal

Prevalence and characteristics of domestic violence in a sample of adult psychiatric outpatients: A cross-sectional study.

L'Encephale·2026
Same journal

From representations to practice: how professionals describe supporting parents with psychiatric or somatic illness or disability.

L'Encephale·2026
See all related articles

Related Experiment Video

Updated: Feb 5, 2026

Measuring the Switch Cost of Smartphone Use While Walking
07:00

Measuring the Switch Cost of Smartphone Use While Walking

Published on: April 30, 2020

2.2K

[Switching and stopping antidepressants].

C Gauthier1, P Abdel-Ahad1, R Gaillard2

  • 1Service hospitalo-universitaire, centre hospitalier Sainte-Anne, 1, rue Cabanis, 75014 Paris, France.

L'Encephale
|September 5, 2018
PubMed
Summary
This summary is machine-generated.

Switching antidepressants is common for major depressive disorder (MDD) non-responders. Careful strategy and close observation are crucial to minimize risks like discontinuation symptoms and relapse during antidepressant transitions.

Keywords:
AntidepressantsAntidépresseursDepressionDépressionSwitch

More Related Videos

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth
09:14

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth

Published on: August 11, 2011

16.3K
High-Contrast and Fast Photorheological Switching of a Twist-Bend Nematic Liquid Crystal
06:24

High-Contrast and Fast Photorheological Switching of a Twist-Bend Nematic Liquid Crystal

Published on: October 31, 2019

6.9K

Related Experiment Videos

Last Updated: Feb 5, 2026

Measuring the Switch Cost of Smartphone Use While Walking
07:00

Measuring the Switch Cost of Smartphone Use While Walking

Published on: April 30, 2020

2.2K
An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth
09:14

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth

Published on: August 11, 2011

16.3K
High-Contrast and Fast Photorheological Switching of a Twist-Bend Nematic Liquid Crystal
06:24

High-Contrast and Fast Photorheological Switching of a Twist-Bend Nematic Liquid Crystal

Published on: October 31, 2019

6.9K

Area of Science:

  • Psychiatry
  • Clinical Pharmacology

Background:

  • Major Depressive Disorder (MDD) affects 20% of the population and is often disabling.
  • Antidepressant treatment is only partially effective, with up to 60% of patients not responding to initial therapy.
  • Switching antidepressants is a frequent strategy for non-responders.

Purpose of the Study:

  • To summarize recommendations for optimal antidepressant switching strategies.
  • To inform clinicians and patients about safe and effective antidepressant transitions.

Main Methods:

  • Review of current clinical practices and literature on antidepressant switching.
  • Analysis of factors influencing the choice of switching strategy.

Main Results:

  • Antidepressant switching requires careful consideration of drug properties and patient factors.
  • Abrupt cessation can lead to discontinuation symptoms; relapse or exacerbation of depression is possible.
  • A tailored switching strategy, under close medical supervision, is essential.

Conclusions:

  • Optimal antidepressant switching minimizes risks and improves treatment outcomes for MDD.
  • Informed patient communication regarding potential side effects and monitoring is vital.
  • This article provides a framework for cautious and effective antidepressant transitions.